Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endemic characteristics of SARS-CoV-2 infection
Igor Nesteruk
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Deciphering Fc-effector functions against SARS-CoV-2
Guillaume Beaudoin-Bussières, Andrés Finzi
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 756-768
Closed Access | Times Cited: 5
Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)
Pia Gattinger, Liubov I. Kozlovskaya, Alexander S. Lunin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
General SIR model for visible and hidden epidemic dynamics
Igor Nesteruk
Frontiers in Artificial Intelligence (2025) Vol. 8
Open Access
Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Should we ignore SARS-CoV-2 disease?
Igor Nesteruk
Epidemiology and Infection (2024) Vol. 152
Open Access | Times Cited: 1
COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection
Aniza P. Mahyuddin, Hannah L F Swa, Ruifen Weng, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107121-107121
Closed Access | Times Cited: 1
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
Roberto Debbag, Deborah Rudin, Francesca Ceddia, et al.
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
Can we start to ignore the SARS-CoV-2 disease?
Igor Nesteruk
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice
Alessandro Del Re, Silvia Basili Franzin, Jie Lu, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Predicting survival in patients with SARS-CoV-2 based on cytokines and soluble immune checkpoint regulators
Nuri Lee, Kibum Jeon, Min-Jeong Park, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
SARS-CoV-2 Omicron Envelope T9I adaptation confers resistance to autophagy
Susanne Klute, Rayhane Nchioua, Arne Cordsmeier, et al.
(2024)
Closed Access
Reduced Cross-Protective Potential of Omicron Compared to Ancestral SARS-CoV-2 Spike Vaccines Against Potentially Zoonotic Coronaviruses
Tyler M. Renner, Matthew Stuible, Brian Cass, et al.
Research Square (Research Square) (2024)
Open Access
Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study
Hyun Ji Kang, Hye‐Jin Kim, Jiwon Jung, et al.
The Journal of Infectious Diseases (2024) Vol. 231, Iss. 2, pp. 392-402
Closed Access
Wastewater-based surveillance of respiratory viruses in Northern Tuscany (Italy): Challenges and added value for public health purposes
Annalaura Carducci, Ileana Federigi, Alessandra Almeida Castro Pagani, et al.
The Science of The Total Environment (2024) Vol. 957, pp. 177752-177752
Open Access
SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients
Mohammad Asrar Izhari
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1653-1667
Open Access
Reduced cross-protective potential of Omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses
Tyler M. Renner, Matthew Stuible, Brian Cass, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Effective, but Safe? Physiologically Based Pharmacokinetic (PBPK)-Modeling-Based Dosing Study of Molnupiravir for Risk Assessment in Pediatric Subpopulations
Sarang Mishra, Katharina Rox
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4112-4122
Closed Access
General SIR model for visible and hidden epidemic dynamics
Igor Nesteruk
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
Clinical Infectious Diseases (2023) Vol. 79, Iss. 1, pp. 274-275
Closed Access | Times Cited: 1
Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission
Madeleine F. Jennewein, Michael D. Schultz, Samuel Beaver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1

Scroll to top